Of patients newly initiated on statin treatment, one-fifth experienced a decrease in HDL-C. |
This HDL-C decrease was associated with higher risk of major adverse cardiovascular events compared with unchanged HDL-C. |
Statin induced HDL-C decrease might be more hazardous than previously recognised and patients should be monitored closely regarding potential cardiovascular risk. |